Ant International’s Alipay+ to become Official Payment Partner of the Laver Cup
16.9.2025 07:24:00 CEST | Business Wire | Press Release
Laver Cup and Alipay+, part of Ant International, a leading global digital payment, digitization and financial technology provider, today formally announce a new long-term strategic partnership which will begin at Laver Cup San Francisco 2025, to be held at the Chase Center from September 19-21.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915513539/en/
The unified global wallet gateway Alipay+, along with WorldFirst and Antom – which are operated by Ant International – will become the Official Payment Partner of the Laver Cup through 2029. Ant Group's flagship service Alipay, an all-in-one digital platform for daily services in China will also join Alipay+ in the partnership.
Ant International, with its associated brands Alipay+, WorldFirst and Antom, and Ant Group’s Alipay will play an important role in supporting the Laver Cup to drive fanbase growth and engagement in the Asia-Pacific region via its digital payment partners which serve over 1.7 billion consumers.
“We are delighted to formally announce the launch of this strategic relationship with Alipay+ and associated payment partners," said Steve Zacks, Laver Cup CEO.
“This collaboration brings together two global entities committed to creating exceptional experiences and connecting fans worldwide through the synergy of sport and technology. We are looking forward to growing our fanbase in Asia while supporting Alipay+ with growth in their key markets.”
Ant International has collaborated on prestigious sporting partnerships around the world, including UEFA EURO 2024 in Germany, and with Tottenham Hotspur Football Club in the UK, leveraging its strengths to drive digital engagement and financial inclusion for local businesses.
Peng Yang, Ant InternationalCEO said: "As a financial technology provider committed to driving inclusive growth for businesses of all sizes with our innovative solutions, Ant International is deeply inspired by what the Laver Cup stands for: unrelenting pursuit of excellence among a community of the best and the bravest.”
“We look forward to supporting the Laver Cup with creative branding, marketing and fan engagement activities throughout our ecosystem of customers and partners across 200 markets, to further spread its vision and inspiration. We are joining hands to build a lasting legacy that will connect new generations of fans in every corner of the globe.”
Ant International offers seamless and secure payment solutions to users across more than 200 countries and regions. Renowned for its cutting-edge technology and commitment to innovation, Alipay+ has become a trusted solution for digital transactions, enabling businesses and consumers to thrive in a rapidly evolving digital landscape.
The Laver Cup pits six of the best men’s tennis players from Europe against six of their counterparts from the rest of the World in a three-day tournament named in honor of Australian tennis legend Rod Laver, the only man to win two calendar-year Grand Slams.
Played on a dramatic black court, the competition alternates annually between Europe and ’rest of the world’ cities. The Laver Cup’s eighth edition will take place this coming weekend at the iconic Chase Center in San Francisco, from September 19-21.
A very limited number of Laver Cup 2025 tickets remain. Tickets are still available for Open Practice Day presented by FICO held on Thursday, September 18, for $20 ($31.65 inclusive of fees). All tickets can be purchased through Ticketmaster, the official ticketing partner of the Chase Center.
For further event updates, news, special offers and more, fans are encouraged to register as a ‘Laver Cup Insider’ at lavercup.com.
– Ends –
The Laver Cup is a joint initiative between TEAM8, Tennis Australia, the USTA and Jorge Paulo Lemann and is an official part of the ATP Tour calendar, with results recorded on official player records.
The Laver Cup is supported by Founding Partner Rolex and Global Sponsors UBS, Mercedes-Benz and Alipay+.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250915513539/en/
Contacts
For further media information please contact:
Emily Wright, media@lavercup.com
For further media information on Alipay+, please contact:
Joshua Way, joshua.way@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom